Cronos Group (TSE:CRON) Shares Up 0.3% – Still a Buy?

Shares of Cronos Group Inc. (TSE:CRON) were up 0.3% during mid-day trading on Friday . The stock traded as high as C$3.76 and last traded at C$3.76. Approximately 81,193 shares changed hands during trading, a decline of 60% from the average daily volume of 200,658 shares. The stock had previously closed at C$3.75.

Cronos Group Price Performance

The company has a quick ratio of 24.01, a current ratio of 24.24 and a debt-to-equity ratio of 0.17. The company has a market cap of C$1.44 billion, a price-to-earnings ratio of 34.18, a price-to-earnings-growth ratio of 0.12 and a beta of 1.30. The company has a fifty day simple moving average of C$3.61 and a two-hundred day simple moving average of C$3.33.

Cronos Group (TSE:CRON) last released its quarterly earnings results on Thursday, November 6th. The company reported C$0.07 earnings per share (EPS) for the quarter. Cronos Group had a negative return on equity of 4.40% and a negative net margin of 42.65%.The business had revenue of C$50.60 million during the quarter. On average, equities research analysts anticipate that Cronos Group Inc. will post -0.26 earnings per share for the current fiscal year.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.